Rose ...yes ...imagine trying to raise funds in the capital markets now ....with the Dow down over 700 pts
For those that hate the idea of " raise when you can not when you need to ".....think about that .
I'll throw out another possible positive catalyst that some may not remember . The final ICER report ...if they agree to include revascularisation that is a huge cost savings over 5 yrs ...as per Dr Bhatt's analysis .....if that's include that in their final report ....it's going to make Vascepa even better on the cost/ benefit analysis .